Penpulimab Combined With RMA Treatment of Primary Diagnosis of Primary Central Nervous System Lymphoma
Clinical trial NCT05347641 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05347641
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2025-06-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.